Company Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
42.2 ^TWD	-3.10%		-1.97%	-35.18%

14/03	Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
06/02	Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer	CI

Tanvex BioPharma, Inc. is a Cayman Islands-based biopharmaceutical company focused on the biosimilar market. The company has expertise in areas, including strain and cell-line development in both microbial and mammalian systems, cell culture, protein purification, process scale-up, drug substance and product manufacturing, and others. The Companyâs product pipeline includes Neupogen (TX-01), Herceptin (TX-05), Neulasta (TX-04), Avastin (TX-16), Perjeta (TX-52), and others. The Company offers a vertically integrated manufacturing platform for biopharmaceuticals. The Company is developing and delivering biologic and biosimilar drugs to people.

TWD in Million	2022	Weight	2023	Weight	Delta
Biopharmaceuticals 100.0 %	22	100.0 %	61	100.0 %	+174.11%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 87.4 %	22	100.0 %	54	87.4 %	+139.70%
United States 12.6 %	0	0.0 %	8	12.6 %	-

Managers	Title	Age	Since
Kuan Hao Lin DFI	Director of Finance/CFO	-	18/22/18

Members of the board	Title	Age	Since
ALLEN Chao FOU	Founder	78	08/13/08
Ta Meng Tseng BRD	Director/Board Member	66	06/13/06
Chih Chuan Chen BRD	Director/Board Member	-	06/13/06
Tai Chang Wang BRD	Director/Board Member	65	27/21/27
Chin Pao Tsai BRD	Director/Board Member	-	15/15/15
Lin Zheng Chen CEO	Chief Executive Officer	-	15/15/15
Cheng Hsia BRD	Director/Board Member	-	15/15/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	164,026,867	98,110,867 ( 59.81 %)	0	59.81 %

Tanvex BioPharma, Inc.

No.376, Sec. 4, Ren'ai Road Daan District

106434, Taipei

http://www.tanvex.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
TANVEX BIOPHARMA, INC.	-35.18%	22Cr
VERTEX PHARMACEUTICALS INCORPORATED	+5.33%	11TCr
REGENERON PHARMACEUTICALS, INC.	+12.11%	11TCr
BIONTECH SE	-12.56%	2.23TCr
ARGENX SE	-3.70%	2.19TCr
GENMAB A/S	-6.03%	1.86TCr
WUXI APPTEC CO., LTD.	-35.21%	1.81TCr
BEIGENE, LTD.	-10.86%	1.7TCr
NEUROCRINE BIOSCIENCES, INC.	+5.10%	1.37TCr
SAREPTA THERAPEUTICS, INC.	+37.57%	1.24TCr

Bio Therapeutic Drugs